AzTrials
AzTrials

Frozen ShoulderNCT05979974

High Energy Density Pulse Electromagnetic Field for Patients With Frozen Shoulder

A study testing High energy density pulse electromagnetic field and physiotherapy in people with Frozen Shoulder, run by Tri-Service General Hospital (TSGH) at 1 site in Taiwan.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The aim of our study is to investigate the efficacy of high energy density pulse electromagnetic field for patients with frozen shoulder Read more about this study

Who is it for?
Ages 20 to 75 years
Conditions the study is for
Frozen Shoulder
What is being tested?
High energy density pulse electromagnetic field and physiotherapy
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
17 participants
Where
1 siteTaiwan
Study dates
31 Oct 2023to 30 Nov 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Frozen shoulder is diagnosed by physicians based on the patient's medical history, physical examination, X-ray, and ultrasound reports.
  • The symptoms persist for more than 3 months.
  • There is a reduction of at least 30 degrees in at least two of the affected shoulder joint angles compared to the angles of the healthy side: shoulder flexion, abduction, and external rotation.

Who cannot join

  • Shoulder musculoskeletal ultrasound reveals a full-thickness tear or massive tear of the shoulder rotator cuff tendons or calcific tendinitis.
  • Systemic rheumatic disease.
  • History of shoulder fracture or previous surgical treatment of the shoulder joint.
  • Acute cervical nerve root compression.
  • Patients with instability (e.g., those with symptoms of internal bleeding) or cancer patients.
  • Received shoulder injections for treatment within the past 3 months.
Show all 9Show fewer
  • Impaired cognitive function that prevents the patient from providing informed consent or participating in rehabilitation therapy.
  • Pregnant or breastfeeding women.
  • Meets any of the contraindications for high-energy electromagnetic pulse therapy: organ transplant recipients; individuals with implanted cardiac pacemakers, defibrillators, metal implants (such as stents), cochlear implants, and insulin supplementation.

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Tri-service general hospital

    Taipei

Other trials in Taiwan

About this study

Official title: Efficacy of High Energy Density Pulse Electromagnetic Field for Patients With Frozen Shoulder: A Double-blinded, Randomized Controlled Trail

The aim of our study is to investigate the efficacy of high energy density pulse electromagnetic field for patients with frozen shoulder

Read the detailed description

Frozen shoulder causes shoulder pain and limited range of motion(ROM). It is thought to afflict between 2 and 5% of the general population. Individuals of middle age are most often affected, typically during the 5th to 7th decades of life. Typical symptoms include gradual onset of shoulder pain, limited shoulder ROM at least in two or more directions (especially in external rotation). In the case of primary adhesive capsulitis, the disease is usually self-limiting, and typically lasts 18-24 months. However, persistent symptoms and movement restriction beyond 3 years have been reported in up to 40% of patients, with up to 15% of patients suffering permanent disability. Therefore, an effective treatment is necessary to treat the shoulder pain and disability caused by frozen shoulder. High energy density pulse electromagnetic field (High-PEMF), different from traditional PEMF, includes characteristics as following:

  1. The short pulse duration (50μs) with a damped oscillation
  2. The broad bandwidth(200kHz~300MHz) with a basic frequency 240kHz
  3. High voltages (up to 40 kV) and peak currents (up to 10 kA) arise in the applicator spool
  4. Delivery of energy per pulse of about 96Ws (Joule) with a magnetic flux density of 50~100mT
  5. Depth penetration for tissue and organ up to 20 cm

It has been applied in chronic tendinopathy with positive outcomes. However, few studies support its application in the setting of frozen shoulder. Hence, the aim of our study is to investigate the efficacy and the underlying possible mechanism of High-PEMF for patients with frozen shoulder.

Conditions
Frozen Shoulder
Being tested
High energy density pulse electromagnetic field, physiotherapy, sham High energy density pulse electromagnetic field
Keywords
Frozen Shoulder, high energy density pulse electromagnetic field
Medical subject headings
Bursitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High energy density pulse electromagnetic fieldDevice

    The treatment coil is placed over the shoulder region at the maximum pain point for 9 minutes. A high energy of high-PEMF with a rate of 3 pulse per second is applied to the patient.

  • physiotherapyOther

    Physiotherapy such as shoulder passive and active-assisted range of motion (ROM) exercises, Pendulum exercises, Codman's exercises and Cross-body reach exercises. Under the physiotherapist's guidance, the patient receives the training session about 30 minutes every time.

  • sham High energy density pulse electromagnetic fieldDevice

    The sham treatment coil is placed over the shoulder region at the maximum pain point for 9 minutes. The setting is the same as the experimental group(high energy, a rate of 3 pulse per second) with the difference that the energy output doesn't export to the patient.

Study groups in NCT05979974
Study groupRoleWhat they receive
physiotherapy and high-PEMFExperimentalThe patient undergoes physiotherapy and high-PEMF therapy twice a week, for a duration of three weeks.
Receives: Device: High energy density pulse electromagnetic field; Other: physiotherapy
physiotherapy and sham high-PEMFSham comparatorThe patient undergoes physiotherapy and sham high-PEMF therapy twice a week, for a duration of three weeks.
Receives: Other: physiotherapy; Device: sham High energy density pulse electromagnetic field

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in pain Visual Analogue Scale(VAS)

    The visual analogue scale (VAS) is a scale used to determine the pain intensity experienced by individuals. "0" means painless and "10" means extremely painful.

    Measured: the change from baseline, post-intervention immediately, post-intervention 1, 3, 6 months

Secondary outcomes (1)
  1. Change in Shoulder Pain and Disability Index (SPADI)

    Shoulder function and disability were evaluated using the Chinese version of the Shoulder Pain and Disability Index (SPADI), a self-report questionnaire that yields pain and disability domain and total scores. The SPADI includes five questions on pain and eight questions on disability, referring to various problems with the shoulder encountered over the preceding week. Each item's score ranges from 0 (no pain/normal) to 10 (maximal pain/disability), with total scores of pain from 0-50 and disability from to 0-80. A higher score shows more disability.

    Measured: the change from baseline, post-intervention immediately, post-intervention 1, 3, 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2023
  2. Study start31 Oct 2023
  3. Primary completion15 Oct 2024
  4. Study completion30 Nov 2024

Why it stopped: Unable to find participants willing to join the trial.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
17 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05979974
Sponsor's protocol ID
A202305106
Status last verified
Dec 2024
First submitted
30 Jul 2023
Last updated
3 Jan 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing High energy density pulse electromagnetic field and physiotherapy in people with Frozen Shoulder, run by Tri-Service General Hospital (TSGH) at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 3 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Unable to find participants willing to join the trial.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in pain Visual Analogue Scale(VAS) (time frame: the change from baseline, post-intervention immediately, post-intervention 1, 3, 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in